Workflow guide · Daily monitoring and portfolio risk
Detect portfolio-changing news before the open
Build a pre-market routine for the events that cannot wait.
The situation
When this workflow becomes useful
Material biotech news arrives overnight or during the pre-market window, leaving a small team limited time to determine which positions require immediate attention.
Best fit
Portfolio managers, analysts, associates, and operations leads at small healthcare and event-driven investment funds.
The challenge
Why the obvious approach breaks down
Build a pre-market routine for the events that cannot wait. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information.
How to think about the task
The reasoning behind the workflow
Material biotech news arrives overnight or during the pre-market window, leaving a small team limited time to determine which positions require immediate attention. For small fund teams, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again.
Build a pre-market routine for the events that cannot wait. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later.
Start with the decision this work must support
“Detect portfolio-changing news before the open” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful.
Build a source-linked change record
The core monitoring set for this workflow includes overnight portfolio-company releases, regulatory and clinical events, sec filings and financings, competitor read-through, pre-market ownership and escalation. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot.
Turn monitoring into an owned output
A pre-market exception report ordered by portfolio impact, urgency, source confidence, assigned owner, and required decision time. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. The team begins the trading day with an agreed priority list instead of discovering material events through price movement.
Illustrative example
Illustrative workflow: detect portfolio-changing news before the open
Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change.
Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event.
Questions to answer before making a decision
- What has changed in overnight portfolio-company releases, and why does it matter?
- What has changed in regulatory and clinical events, and why does it matter?
- What has changed in sec filings and financings, and why does it matter?
- What has changed in competitor read-through, and why does it matter?
- What has changed in pre-market ownership and escalation, and why does it matter?
The workflow
A repeatable way to do the work
- 01
Define the specific decision or research question behind “detect portfolio-changing news before the open.”
- 02
Set the monitored scope around overnight portfolio-company releases and regulatory and clinical events.
- 03
Collect source-linked updates for sec filings and financings and record what changed from the prior state.
- 04
Review competitor read-through together with pre-market ownership and escalation before drawing a conclusion.
- 05
Produce the required output, assign follow-up ownership, and set the next review point.
Monitoring checklist
Signals to keep visible
Common mistakes
- Starting the monitoring process without a defined decision question
- Recording the latest state without preserving its source or previous state
- Ending with collected information but no owner, conclusion, or next review
Output and outcome
What good looks like
Deliverable
A pre-market exception report ordered by portfolio impact, urgency, source confidence, assigned owner, and required decision time.
Practical outcome
The team begins the trading day with an agreed priority list instead of discovering material events through price movement.
Where BioPharmSignal fits
Reduce the collection work around the decision.
Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep the relevant tickers and keywords visible. The workflow still requires independent research and judgment.
Frequently asked questions
Who is this workflow for?
It is designed for small biotech fund teams and adjacent biotech research users who need a repeatable, source-linked way to complete this task.
What should this workflow produce?
A pre-market exception report ordered by portfolio impact, urgency, source confidence, assigned owner, and required decision time.
What is the practical benefit?
The team begins the trading day with an agreed priority list instead of discovering material events through price movement.
Related workflows